Principal Investigators:

• BreAnna Kinghorn, University of Washington, Seattle, Washington 
• Margaret Rosenfeld MD MPH, University of Washington, Seattle, Washington 
• Scott Sagel, MD PhD, University of Colorado, Denver, Colorado 
• Adam Shapiro, MD, McGill University, Montreal, Quebec.

Steering Committee:

• Stephanie Davis MD, University of North Carolina, Chapel Hill, North Carolina 
• Margaret Leigh, University of North Carolina, Chapel Hill, North Carolina
• Tom Ferkol MD, Washington University, St. Louis, Missouri
• Steve Lommatzsch MD, National Jewish Health, Denver Colorado

Presenting Faculty:

• Ric Boucher, MD
• Jim Chmiel, MD
•  Megan Cooper, MD
•  Stephanie Davis, MD
• Sharon Dell, MD
• Christopher Evans, Ph.D.
• Tom Ferkol, MD
• Nicole Hamblett, PhD
• Steve Holland, MD
• Margaret Leigh, MD
• John Lipuma, MD, PhD
• Michele Manion
• Jerry Nick, MD
• Michael O’Conner, MD
• Jessica Pittman, MD, MPH
• Deepika Polineni, MD 
• Bonnie Ramsey, MD
• Robert Sandhaus, MD, PhD
• Kathryn Stephens

Faculty for the Meet The Experts Session:

Primary Immune Deficiency:
John M. Routes, MD
Chief, Section of Allergy and Clinical Immunology
Professor of Pediatrics, Medicine, Microbiology and Immunology
Department of Pediatrics
Children's Wisconsin
Medical College of Wisconsin

Dr. Routes is a clinical immunologist whose practice is limited to the evaluation and treatment of children and adults with primary immunodeficiencies.  Dr. Routes was the principal investigator for the first statewide program (Wisconsin) to screen all newborns for severe combined immunodeficiency (SCID). He has a longstanding interest in lung disease in primary immunodeficiency and was first to describe granulomatous and lymphocytic interstitial lung disease (GLILD) as a unique disease that occurs in CVID and CVID-like disorders and is distinct from sarcoidosis. More recently, Dr. Routes and collaborators published the results on the use of immunosuppressive regimen that improves the pulmonary abnormalities due to GLILD on a large cohort of patients.  Dr Routes served as a member (2009-2017) then the Chair (2017-2019) of the NIH study section "Investigations in Primary Immunodeficiencies". He is the past President of the Clinical Immunology Society (2013-2014) and in 2016 received the CIS Distinguished Service Award.

Alpha-1 Foundation:
Robert A. Sandhaus, MD, PhD, FCCP
Professor of Medicine
Division of Pulmonary, Critical Care, and Sleep Medicine
Director, Alpha-1 Antitrypsin Deficiency Program
National Jewish Health

Robert “Sandy” Sandhaus graduated from Haverford College in Pennsylvania with a degree in molecular biology.  He received a PhD in cell biology from Stony Brook University and an MD from the Renaissance School of Medicine.  He completed his residency in internal medicine at the Beth Israel Hospital in Boston and a pulmonary fellowship at the University of California San Francisco (UCSF).
He joined the UCSF medical faculty and subsequently the medical faculty at the University of Colorado School of Medicine where he founded the Alpha-1 Antitrypsin Deficiency Program at National Jewish Health in Denver 40 years ago.  He remains its director. Currently, he serves on the medical advisory committees of the COPD Foundation and the Osteogenesis Imperfecta Foundation.  He has been board certified in internal medicine, pulmonary disease, and critical care medicine and lives in Bow Mar, Colorado.

PCD Foundation:
Thomas G. Saba, MD 
Assistant Professor
Pediatric Pulmonology Fellowship Program Director
Primary Ciliary Dyskinesia Center Director
C.S. Mott Children's Hospital
University of Michigan

Thomas Saba graduated from Medical school at McGill University.  He completed his pediatric residency, serving as Chief Pediatric Resident at Montreal Children's Hospital. Following residency, he completed a pediatric pulmonology fellowship at the University of Michigan. Currently, Dr. Saba is a clinician educator and the fellowship program director. His clinical research interests include PCD and heterotaxy syndrome and is a member of the ATS training committee.

Steve Brody, MD
Professor of Medicine
Dorothy R and Hubert C. Moog Professor of Pulmonary Medicine
Washington University School of Medicine in Saint Louis

Steven L Brody, MD is the Moog Professor of Pulmonary Medicine at Washington University School of Medicine in Saint Louis. He received his MD at the University of Michigan and residency training in internal medicine at the University of Cincinnati. He trained in emergency medicine and critical care at Emory University followed by a fellowship in pulmonary medicine and post-doctoral research at the National Institutes of Health. His laboratory uses cell and molecular biology tools to investigate airway epithelial function, ciliated cell commitment and ciliogenesis. His group has specific interest in steps required for cilia assembly and the impact of mutations found in primary ciliary dyskinesia.